Leukemia News and Research

RSS
Leukemia (Leukaemia) is a cancer of the blood cells. It is the most common type of blood cancer and affects 10 times as many adults as children. Most people diagnosed with leukemia are over 50 years old. No one knows why some people develop leukemia and others do not. However, scientists have identified some risk factors for the disease. Most people who have known risk factors do not get leukemia, while many who do get the disease have none of these risk factors. During the early stages of leukemia, there may be no symptoms. Many of the symptoms of leukemia don't become apparent until a large number of normal blood cells are crowded out by leukemia cells.
Combination of obatoclax and flavopiridol triggers multiple myeloma cell death

Combination of obatoclax and flavopiridol triggers multiple myeloma cell death

Targeting elevated HLX gene expression may treat acute myeloid leukemia

Targeting elevated HLX gene expression may treat acute myeloid leukemia

Scientists identify new genetic alterations underlying high-risk subtype of ALL

Scientists identify new genetic alterations underlying high-risk subtype of ALL

Researchers uncover how pathological cells activate themselves in chronic lymphocytic leukaemia

Researchers uncover how pathological cells activate themselves in chronic lymphocytic leukaemia

FDA approved drug to treat Ph- acute lymphoblastic leukemia

FDA approved drug to treat Ph- acute lymphoblastic leukemia

Longer looks: Waking up to the need for sleep

Longer looks: Waking up to the need for sleep

Work solvent-related brain tumor concerns allayed

Work solvent-related brain tumor concerns allayed

New research center to expedite study of gene transfer approach

New research center to expedite study of gene transfer approach

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

NeoGenomics introduces new molecular assay that detects SF3B1 gene mutations

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

Novartis, Penn partner to study and commercialize novel cellular immunotherapies for cancer

Researchers identify how telomerase is recruited to chromosome ends

Researchers identify how telomerase is recruited to chromosome ends

NYGC purchases four Life Technologies' Ion Proton Sequencers

NYGC purchases four Life Technologies' Ion Proton Sequencers

Population Genetics validates GenomePooling™ for cancer

Population Genetics validates GenomePooling™ for cancer

GenomePooling™ method is sensitive and accurate

GenomePooling™ method is sensitive and accurate

TAU researcher reveals link between plant and human biology

TAU researcher reveals link between plant and human biology

Traditional cures provide economic benefits

Traditional cures provide economic benefits

Viewpoints: Health law no threat to innovation; Failure to expand Medicaid would 'doom' thousands; Don't stigmatize mentally ill

Viewpoints: Health law no threat to innovation; Failure to expand Medicaid would 'doom' thousands; Don't stigmatize mentally ill

New assay method finds evidence of clonal evolution in chronic lymphocytic leukemia

New assay method finds evidence of clonal evolution in chronic lymphocytic leukemia

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

ARIAD Pharmaceuticals commences ponatinib Phase 3 trial in newly diagnosed CML

PedBrain Tumor network publishes evaluation of first 125 genome analyses of medulloblastomas

PedBrain Tumor network publishes evaluation of first 125 genome analyses of medulloblastomas

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.